Developing Practical Single-Use Processes for New Vaccine Formulations
Posted on April 18, 2017
Kirsten A. Strahlendorf, P. Eng., M. Eng., Senior Scientist
Sanofi Pasteur
New vaccine process designs – and all the kinks that go with them – are typically hammered out in a small scale capacity, for example, prior to manufacturing for early phase human clinical trials. They are then upsized and further defined for industrial scale to supply the vast market. Single-us...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
biopharmaceutical applications, elimination of glass, Kirsten Strahlendorf, monitoring particulates, New vaccine process designs, reduced CAPEX, Sanofi-Pasteur, single use processes, Single-use technologies, sterility assurance, SUTs, vaccine manufacturing
Related Product Videos
Related Products
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
